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chapter, giving the feeling that this volume marks 
a milestone in progress and generating a real en- 
thusiasm for the future. The authors of the re- 
maining nine chapters each consider a different 
contrasting ecological situation giving details of 
relevant physical and geographical characteristics, 
as well as reviewing current knowledge of 
photosynthetic performance in relevant en- 
vironmental conditions. The first type of environ- 
ment is that of deserts and S.D. Smith and P.S. 
Nobel describe avariety of strategies for photosyn- 
thesis under extreme water stress and temper- 
atures. The problems of saline terrestrial 
environments are dealt with by S.P. Long and 
N.R. Baker and along with the chapter on cold 
climates by G. Oquist and B. Martin they cover 
areas in which there is the greatest detail available 
on advancements at the biochemical level. The re- 
maining land based environments are wetlands 
(M.B. Jones), forests, savannas and montane 
tropical environments (E. Medina), temperate 
grasslands (J. Woledge and A.J. Parsons) and 
temperate forests (P.G. Jarvis and A.P. Sand- 
ford). These chapters are primarily concerned with 
plant photosynthetic performance, particularly in 
the context of problems of light interception, 
gaseous exchange and nutrient supply. This is also 
true of the chapters on freshwater (J.T.O. Kirk) 
and marine (J.A. Raven and K. Richardson) 
aquatic environments. 
As with other volumes in the series a particularly 
helpful format is followed and there is a com- 
prehensive and useful subject index. Each chapter 
is subdivided into brief sections with subheadings 
which are presented in a contents list at the start of 
each chapter, along with an explanation of ab- 
breviations. These features are welcome but the 
overall standard of the production is marred by the 
over-reduction i  size of many of the figures, often 
with loss of clarity and through bad planning the 
imposition of large blank areas on some pages. 
This appears to be a cost cutting exercise which has 
been taken too far and is not in keeping with the 
achievements of the authors in contributing to an 
impressive array of knowledge which maintains the 
high standards et in this series. 
David J. Chapman 
Site-Specific Drug Delivery 
Edited by E. Toml inson and S.S. Davis 
John Wiley and Sons; Chichester, 1986 
x + 164 pages. £20.00 
The differentiation i the concentration of an ac- 
tive agent in favour of a target tissue is a long- 
standing therapeutic objective. However, tentative 
realisation has only become apparent recently 
through fundamental principles established by the 
immunologist, he genetic engineer, the virologist, 
the colloid scientist and the biochemist. This book 
brings together nine contributions from this wide 
spectrum and pleads for their integration into the 
overall process of drug design. For success, a 
multidisciplinary attack is essential. 
Individual contributions range from reviews to 
detailed descriptions of particular receptor- 
dependent targets and the drug carriers with which 
they interact. The easier targets found within the 
vasculature or the reticuloendothelial system com- 
mand obvious attention. However, most of the 
book addresses the issues of extravasation fol- 
lowed by attack at the extracellular or intracellular 
level using principles as diverse as the im- 
munomodulation of macrophages, tissue tropisms 
among viruses and the surface modification of col- 
loidal particles. 
Site-specific drug delivery is a rapidly growing 
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subject presenting reat technical promise but sub- 
ject to considerable hyperbole. This book is a 
sober articulate statement which points the way 
forward, defining interdisciplinary opportunities 
without minimising the complexity and difficulties 
such scientific interaction will bring. 
D. Ganderton 
Receptor Binding in Drug Research (Clinical Pharmacology, 
Vol. 6) 
Edited by Robert  A. O 'Br ien  
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In the Foreword to this book it is suggested that 
'binding techniques.., are now truly relevant o the 
needs of mankind'.  However, there can be no 
doubt that receptor binding as a methodology has 
become a 'mature'  science and an accepted way of 
life in drug research. It is a commercially viable 
technique and this text reflects such a drug 
development perspective. The coverage of this vast 
literature is not all-inclusive, as th~ Editor's stated 
intention is '... to present some philosophies for 
use of receptor pharmacology ... in some of the 
most challenging therapeutic areas'. 
The text is divided into five sections. Part I con- 
tains two chapters; one on methodology and 
analysis, and the second on computer analysis. 
Both are well written and would appear to provide 
an excellent introduction to problems and con- 
siderations required in receptor binding studies. 
Whether there is sufficiently in depth information 
in this section to interest he committed 'binder' I
cannot judge. 
The next three sections are devoted to receptor 
screening as applied to (Part II) specific 
therapeutic areas, (Part III) multiple therapeutic 
areas, and (Part IV) peptides, growth factors and 
endogenous ligands. Specific therapies include the 
benzodiazepines, neuroleptics, antidepressants, 
psychomotor stimulants and the opiates. Recep- 
tors with multiple therapeutic implications are 
those for leukotrienes, purines, steroid hormones, 
calcium and muscarinic cholinergic compounds. 
The third of these sections deals with receptors for 
interferon, platelet-derived growth factor, insulin 
and cholecystokinin. Although each chapter pro- 
vides a brief review of the literature, most of the 
text deals with the techniques and the conditions 
required for the particular assay(s) in question. 
Some chapters focus more on methodological 
development (muscarinic cholinergic receptors); 
while, others provide more information on drug 
actions in well established binding protocols. In- 
dividually the chapters are interesting and infor- 
mative, but the format is so repetitive that I found 
it difficult to maintain the necessary concen- 
tration. 
The last chapter in Part IV and all of Part V deal 
with receptor methodologies for identifying en- 
dogenous ligands and new drugs especially an- 
tidepressants, anxiolytics and cholinergic agents. 
Chapter 19 describes attempts and failure to iden- 
tify a benzodiazepine ligand isolated from human 
serum. The authors highlight he problems and pit- 
falls they encountered and by doing so emphasize 
most effectively the need for adequate controls and 
for structural analysis of suspected ligands. Final- 
ly, in the section on drug development there is a 
very interesting discussion of the importance of 
considering possible interactions of a drug with 
more than one receptor system. Binding studies 
generally seem to focus on one receptor, ignoring 
or overlooking possible multiple activities of a 
drug. Yet the importance of such considerations i  
239 
